• M Gomez Duque, C Enciso Olivera, E Peña Torres, O D Segura Durán, and V H Nieto Estrada.
• Comité de Ética en Investigación, CEISH, Hospital Universitario de San José, Bogotá, Colombia.
• Med Intensiva. 2012 Jun 1;36(5):343-50.

ObjectiveTo describe the incidence of cardiovascular adverse events in patients with sepsis in its various stages.DesignA longitudinal, descriptive, observational study was carried out.SettingIntensive care units of two university hospitals in Bogotá (Colombia).PatientsA number of patients consecutively admitted to the adult ICU with a diagnosis of sepsis, and no evidence of previous ischemic myocardial injury.InterventionsForty-eight hours of electrocardiographic record using Holter technology.Main VariablesIschemia, cardiac arrhythmia, heart rate variability.ResultsA total of 100 patients were analyzed, 62% being staged as presenting septic shock. Three percent suffered ischemic events detected by Holter and unnoticed through conventional monitoring. Forty-six percent suffered an arrhythmic event detected by Holter, compared with only 6% as detected by conventional monitoring. Mortality was 40%. All patients showed loss of heart rate variability.ConclusionIn this study patients with sepsis showed a low incidence of cardiovascular ischemic events. In contrast, arrhythmic events showed a high incidence. Conventional monitoring failed to detect any of the ischemic events and most arrhythmic events. In this study, cardiovascular events generated by adrenergic discharge had no impact upon mortality.Copyright © 2011 Elsevier España, S.L. and SEMICYUC. All rights reserved.

44 keywords...

hide…